STEPHEN C FARRELL
CIK 1188757 · President & CEO · last filed 2025-03-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$997.4K
Companies
8
Total Filings
60
Lifetime Open-Market Net
-$4.77M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STAA | President & CEO | 35,156 | $28.37 | $997.4K | $0 | 20 | 2025-03-06 |
| Convey Health Solutions Holdings, Inc. (CNVY) Delisted | CHIEF EXECUTIVE OFFICER | 636,862 | $10.51 | $6.69M | $585.0K | 2 | 2022-03-30 |
| LCTX | Director | — | $1.27 | — | $0 | 1 | 2020-07-02 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 97,450 | — | — | $350.4K | 10 | 2018-07-03 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 15,433 | — | — | -$2.57M | 11 | 2014-03-11 |
| Stream Global Services, Inc. (OOO.WS) Delisted | Executive Vice President & CFO | 3,640 | — | — | $9.1K | 4 | 2008-12-18 |
| QUESTCOR PHARMACEUTICALS INC (QSC) Delisted | Director | — | — | — | $0 | 3 | 2008-01-03 |
| POLYMEDICA CORP (PSTA) Delisted | President | 0 | — | — | -$3.14M | 6 | 2007-11-13 |
Recent Filings · Page 2 of 6
60 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-25 | STAA | Exer (M) | +404 | $0 | EDGAR |
| 2021-06-21 | Convey Health Solutions Holdings, Inc. (CNVY) Delisted | Buy (P) | +45,000 | $585.0K | EDGAR |
| 2021-05-28 | STAA | Mixed | — | -$1.36M | EDGAR |
| 2021-05-21 | STAA | Mixed | — | -$572.3K | EDGAR |
| 2021-05-18 | STAA | Mixed | — | -$568.7K | EDGAR |
| 2020-08-04 | STAA | Grant (A) | +2,117 | $0 | EDGAR |
| 2020-07-02 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2019-07-03 | — | Grant (A) | — | $0 | |
| 2019-06-24 | STAA | Grant (A) | — | $0 | EDGAR |
| 2018-07-03 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.